Efficacy of Acupuncture and Moxibustion Treatment in Patients With Quiescent Crohn's Disease:Evaluation With fMRI
1 other identifier
interventional
61
1 country
1
Brief Summary
The purpose of this study is to determine whether acupuncture or moxibustion therapies are effective in the treatment of Crohn's disease. Meanwhile, the investigators aim to evaluate the efficacy by functional magnetic resonance imaging.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2012
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2012
CompletedFirst Submitted
Initial submission to the registry
September 25, 2012
CompletedFirst Posted
Study publicly available on registry
October 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2014
CompletedSeptember 5, 2016
September 1, 2012
1.6 years
September 25, 2012
September 2, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
CDAI
Crohn's Disease Activity Index
1 year
Secondary Outcomes (4)
fMRI
1 year
IBDQ
1 year
Inflammatory factors
1 and a half years
Neurotransmitter
1 and a half years
Study Arms (2)
EA group
EXPERIMENTALElectroacupuncture group
MOX group
EXPERIMENTALHerbs-partitioned moxibustion group
Interventions
Patients receive electroacupuncture for 30 minutes with a stimulation frequency of 2 /100 Hz and a stimulation intensity varying from 0.1 to 1.0 mA.3 times per week,the duration is 12 weeks.
patients receive herbs-partitioned moxibustion for 2 cones,3 times a week for 12 weeks.
Eligibility Criteria
You may qualify if:
- age 18-50 years;
- right-handed;
- clinical remission (Crohn's Disease Activity Index \[CDAI\]≤150) for at least 6 months prior to the study;
- C-reactive protein(CRP)\<10 mg/l;
- erythrocyte sedimentation rate (ESR) \<20 mm/h
- signing awritten informed consent form.
You may not qualify if:
- use of corticosteroids and psychotropic medications in the previous 30 days;
- current or prior history of neurological or psychiatric disease based
- on physicians' examination and questionnaires;
- current or prior history of neurosurgery, head injury, cerebrovascular
- insult, or brain trauma involving loss of consciousness;
- learning disability;
- claustrophobia;
- presence of metallic implants in the body;
- being pregnant or during lactation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shanghai Institute of Acupuncture-Moxibustion and Merdian
Shanghai, Shanghai Municipality, 200030, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Wu Huangan, PhD
Shanghai Institute of Acupuncture, Moxibustion and Meridian
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 25, 2012
First Posted
October 1, 2012
Study Start
September 1, 2012
Primary Completion
April 1, 2014
Study Completion
November 1, 2014
Last Updated
September 5, 2016
Record last verified: 2012-09